Issue 77, 2015

A peptide-based pH-sensitive drug delivery system for targeted ablation of cancer cells

Abstract

A peptide-guided prodrug incorporating a tumor-specific peptide, doxorubicin, and a pH-sensitive hydrazone bridge was developed for targeted ablation of cancer cells with minimal side cytotoxicity.

Graphical abstract: A peptide-based pH-sensitive drug delivery system for targeted ablation of cancer cells

Supplementary files

Article information

Article type
Communication
Submitted
24 Jun 2015
Accepted
05 Aug 2015
First published
05 Aug 2015

Chem. Commun., 2015,51, 14454-14457

A peptide-based pH-sensitive drug delivery system for targeted ablation of cancer cells

Y. Jin, Y. Huang, H. Yang, G. Liu and R. Zhao, Chem. Commun., 2015, 51, 14454 DOI: 10.1039/C5CC05184C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements